The UK Government are not funding any research into the development of new oral anti-retroviral medication but is funding research into the development of microbicides (vaginal medication) against HIV and AIDS. The International Partnership for Microbicides (IPM) has received £8.7 million between 2002-08 and the Microbicide Development Programme (MDP), a joint programme between the UK Medical Research Council and Imperial College London, has received £39.8 million between 2001-09.
The UK Government are providing £5.6 million for two clinical trials that are developing simplified treatment protocols to use existing oral anti-retroviral therapy in Africa. Both trials are coordinated by the Medical Research Council clinical trials unit—DART (ART for adults 2002-07) and ARROW (ART for children 2006-11).